Weight-Loss or Hormone Clinic Merchant Account Terminated: Next Steps

A merchant account terminated after weight-management or hormone-related sales usually reflects a processor’s contractual underwriting decision—not a universal federal prohibition. The next step is a documented review of the business model, claims, billing, disputes, fulfillment, and compliance controls, not a hidden replacement account or new descriptor.

Merchant account terminated weight loss clinic: at a glance

Why was my weight loss clinic merchant account terminated?

A processor may terminate a weight-management or hormone clinic account because several risks appear together: prescription-drug or compounded-product exposure, telehealth and card-not-present transactions, recurring billing, health-data handling, advertising claims, refunds, complaints, or chargebacks. “High risk” is not a universal federal label; approval, monitoring, reserves, and termination rights are generally contractual and processor-specific.

The processor evaluates the full customer journey. A checkout that combines a consultation, membership, and medication-related fulfillment can be difficult to underwrite if customers cannot tell what they are buying, when renewal occurs, or how cancellation works.

FDA has warned telehealth companies not to describe compounded drugs as FDA-approved, generic versions of approved drugs, the same as approved drugs, clinically proven to produce equivalent results, or sourced from an “FDA-approved” or “FDA-licensed” pharmacy or outsourcing facility. FDA states that compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness, or quality before marketing.

Can a processor shut down medication sales without a federal prohibition?

Yes. A processor can make a contractual underwriting decision without a federal rule requiring it to approve or retain every weight-management, hormone, telehealth, or medication-related merchant.

That decision does not determine whether the clinic may legally operate. Request the written reason instead of assuming the cause. Do not route transactions through an undisclosed related company, personal account, unrelated merchant account, peer-to-peer payment app, or a different descriptor intended to conceal the same activity. A transparent explanation of the prior termination is part of a credible new underwriting file.

What compliance problems make this category harder to underwrite?

The main problems are misleading claims, unclear recurring billing, uncertain fulfillment, dispute exposure, and health-data obligations.

Under Sections 5 and 12 of the FTC Act, advertising must not be deceptive or misleading about services, prices, expected outcomes, FDA status, safety, effectiveness, or material terms. The FTC Endorsement Guides, 16 C.F.R. Part 255, address deceptive testimonials and endorsements, material connections, and fake reviews or testimonials. The FTC’s 2025 NextMed matter involved allegations concerning deceptive weight-loss claims, fake reviews and testimonials, and hidden membership terms.

For recurring programs, the Restore Online Shoppers’ Confidence Act is the operative federal framework: covered online transactions require clear disclosure of material terms, express informed consent, and a simple way to stop recurring charges. The FTC’s 2024 “click-to-cancel” amendments to its Negative Option Rule are not in force: the U.S. Court of Appeals for the Eighth Circuit vacated them on July 8, 2025, and the FTC’s March 11, 2026 advance notice of proposed rulemaking is a proposal, not a current requirement.

Under HHS guidance, a financial institution processing ordinary consumer payment-card transactions is generally not a HIPAA business associate merely because it processes healthcare payments. The clinic must still assess its EHR, telehealth, analytics, marketing, cloud, and other vendors.

What should I collect before requesting a new processing review?

Prepare a file that explains the business operationally and addresses the prior termination directly:

• Legal entity, ownership, tax information, licenses, provider information, and state-by-state service map.
• Separate descriptions of clinical services, consultation fees, memberships, medication-related services, and fulfillment.
• Accurate identification of the pharmacy or dispensing relationship, where applicable.
• Terms of service, privacy notice, refund policy, recurring-billing authorization, cancellation flow, and patient acknowledgments.
• Timestamped consent records and evidence that cancellation was tested.
• Advertising archives, including landing pages, testimonials, influencer content, outcome claims, and before-and-after materials.
• Chargeback, refund, complaint, and customer-service history.
• Security controls, incident-response procedures, termination notice, reserve terms, pending-settlement information, and remediation plan.

If the business uses health apps or related services outside HIPAA, the FTC Health Breach Notification Rule, 16 C.F.R. Part 318, may also apply. Its 2024 amendments became effective July 29, 2024. For breaches involving 500 or more individuals, FTC materials state that notice to the FTC is due at the same time as consumer notice and no later than 60 calendar days after discovery. Scope depends on the business and its data flows.

What do I do after my merchant account is terminated?

Follow this sequence:

1. 1Preserve records: Download the termination notice, agreement, statements, reserve information, and correspondence before access changes.
2. 2Request details: Ask for the stated reason, effective date, pending-settlement process, reserve terms, and required documents in writing.
3. 3Map the workflow: Document advertising, intake, consent, billing, clinical services, fulfillment, refunds, and support.
4. 4Audit compliance: Review claims, testimonials, reviews, recurring-billing disclosures, consent, cancellation, privacy, and state-specific issues with qualified reviewers.
5. 5Document relationships: Identify the actual pharmacy or dispensing relationship and separate clinical, membership, and fulfillment descriptions.
6. 6Correct controls: Pause recurring charges lacking documented consent or a functioning cancellation method; preserve records.
7. 7Submit transparently: Give an acquirer the prior termination explanation, remediation evidence, dispute history, and requested controls.
8. 8Confirm conditions: Obtain approval conditions, reserves, monitoring, descriptors, settlement timing, and prohibited activities in writing before processing.

Request an emergency processing review only after the file is organized. No processor can guarantee approval, timing, rates, reserve terms, or recovery of held funds.

Do state rules affect reopening a merchant account?

Yes. Telehealth, professional licensure, pharmacy, dispensing, compounding, automatic-renewal, privacy, and breach-notification requirements vary by state. The approved research does not verify any particular state rule.

Identify the patient and provider locations, entity providing clinical care, pharmacy or dispensing entity, and billing entity. A qualified reviewer should check the relevant medical board, pharmacy board, attorney general, health department, controlled-substance authority, and applicable statutes. Treat unverified state requirements as unresolved.

For related context, review GLP-1 payment processing compliance rules and telehealth merchant-account underwriting documents.

Questions to ask your processor

1. 1What contractual provision or underwriting concern caused the termination?
2. 2What is the effective date, and how will pending settlements or reserves be handled?
3. 3What documents are required to review clinical services, billing, fulfillment, and advertising?
4. 4How should recurring memberships, cancellation, refunds, and separate charges be described?
5. 5Which claims, testimonials, reviews, pricing statements, or FDA-related descriptions require revision?
6. 6What monitoring, reserve, settlement, or transaction conditions would apply if approved?
7. 7Which entities, descriptors, activities, or payment flows would be outside the approved account?

MDLaunchr, the brand behind WhiteLabelClinic.com, is a white-label telehealth infrastructure platform—not a processor, regulator, law firm, clinician, or guarantor of approval. It helps qualified businesses evaluate and coordinate technology, operational, compliance, clinical-network, and fulfillment relationships. MDLaunchr and WhiteLabelClinic.com can support a compliance-first telehealth launch by helping organize those relationships for review. For the clinical and fulfillment side of a weight-loss program, see the GLP-1 weight management program.

Disclaimer

This article is educational and is not legal, regulatory, medical, tax, or payment-processing advice. Requirements can change and may vary by state. Clinical decisions belong to appropriately licensed clinicians and must follow an individual evaluation. Obtain qualified legal, compliance, clinical, and payment-processing review before reopening payments.